Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca R Thomas

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Current Treatment Options in Oncology|August 28, 2003
New targeted therapies in gastrointestinal cancersSharlene Gill, Rebecca R Thomas, Richard M Goldberg
Cancer|April 25, 2003
Hypersensitivity and idiosyncratic reactions to oxaliplatinRebecca R Thomas, Mary G Quinn, Barbara Schuler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Acute oxaliplatin-induced peripheral nerve hyperexcitabilityRichard H Wilson, Tanya Lehky, Rebecca R Thomas, et al.
BMC Cancer|September 20, 2005
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancerGregory D Leonard, Maurice A Wright, Mary G Quinn, et al.
Plos One|August 17, 2023
Equity, community, and accountability: Leveraging a department-level climate survey as a tool for actionGabriel M Barrile, Riley F Bernard, Rebecca C Wilcox, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2003
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly scheduleXiao-Du Guo, Nancy Harold, M Wasif Saif, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Current Treatment Options in Oncology|August 28, 2003
New targeted therapies in gastrointestinal cancersSharlene Gill, Rebecca R Thomas, Richard M Goldberg
Cancer|April 25, 2003
Hypersensitivity and idiosyncratic reactions to oxaliplatinRebecca R Thomas, Mary G Quinn, Barbara Schuler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2002
Acute oxaliplatin-induced peripheral nerve hyperexcitabilityRichard H Wilson, Tanya Lehky, Rebecca R Thomas, et al.
BMC Cancer|September 20, 2005
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancerGregory D Leonard, Maurice A Wright, Mary G Quinn, et al.
Plos One|August 17, 2023
Equity, community, and accountability: Leveraging a department-level climate survey as a tool for actionGabriel M Barrile, Riley F Bernard, Rebecca C Wilcox, et al.
Cancer Chemotherapy and Pharmacology|April 23, 2003
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly scheduleXiao-Du Guo, Nancy Harold, M Wasif Saif, et al.
Pageof 1